VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q3 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,577,198 | +47.1% | 95,771 | +64.6% | 0.03% | +7.7% |
| Q2 2023 | $1,752,402 | -11.1% | 58,200 | -4.5% | 0.03% | -35.0% |
| Q1 2023 | $1,970,536 | +470.8% | 60,913 | +405.7% | 0.04% | +300.0% |
| Q4 2022 | $345,238 | -72.4% | 12,046 | -76.7% | 0.01% | -73.7% |
| Q3 2022 | $1,249,000 | -22.9% | 51,766 | -12.6% | 0.04% | -34.5% |
| Q2 2022 | $1,621,000 | +82.3% | 59,216 | +155.3% | 0.06% | +87.1% |
| Q1 2022 | $889,000 | -15.2% | 23,194 | -29.1% | 0.03% | -32.6% |
| Q4 2021 | $1,048,000 | -83.9% | 32,730 | -85.1% | 0.05% | -75.8% |
| Q3 2021 | $6,494,000 | +133.4% | 220,373 | +169.2% | 0.19% | +128.9% |
| Q2 2021 | $2,782,000 | +338.8% | 81,868 | +319.9% | 0.08% | +137.1% |
| Q1 2021 | $634,000 | -78.0% | 19,496 | -75.7% | 0.04% | -48.5% |
| Q4 2020 | $2,886,000 | +136.9% | 80,095 | +157.5% | 0.07% | +172.0% |
| Q3 2020 | $1,218,000 | -48.3% | 31,100 | -51.6% | 0.02% | -52.8% |
| Q2 2020 | $2,355,000 | -77.3% | 64,200 | -85.7% | 0.05% | -77.3% |
| Q1 2020 | $10,362,000 | -10.6% | 449,738 | +13.7% | 0.23% | +198.7% |
| Q4 2019 | $11,586,000 | -24.6% | 395,700 | -31.2% | 0.08% | -43.9% |
| Q3 2019 | $15,360,000 | -51.4% | 575,071 | -53.5% | 0.14% | -57.9% |
| Q2 2019 | $31,584,000 | +37.8% | 1,235,680 | +20.9% | 0.33% | +61.0% |
| Q1 2019 | $22,915,000 | +615.9% | 1,022,112 | +573.3% | 0.20% | +425.6% |
| Q4 2018 | $3,201,000 | -77.5% | 151,800 | -80.2% | 0.04% | -57.6% |
| Q3 2018 | $14,219,000 | +149.2% | 767,775 | +200.1% | 0.09% | +217.2% |
| Q2 2018 | $5,707,000 | -41.7% | 255,800 | -42.5% | 0.03% | -47.3% |
| Q1 2018 | $9,781,000 | +168.7% | 445,045 | +184.1% | 0.06% | -43.3% |
| Q4 2017 | $3,640,000 | +292.7% | 156,631 | +287.9% | 0.10% | +14.1% |
| Q3 2017 | $927,000 | +27.9% | 40,376 | +22.9% | 0.08% | -38.4% |
| Q2 2017 | $725,000 | -66.7% | 32,849 | -65.6% | 0.14% | -67.7% |
| Q1 2017 | $2,180,000 | +364.8% | 95,553 | +464.0% | 0.43% | +67.5% |
| Q2 2016 | $469,000 | – | 16,943 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |